Financhill
Back

Roivant Sciences Quote, Financials, Valuation and Earnings

Big Gains Still to Be Had in 2023

Grab a FREE ticket right now on this page!
Sell
28

ROIV
Roivant Sciences

Last Price:
11.67
Seasonality Move:
4.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Prepare now for a ChatGPT IPO announcement

Click here to see more

Roivant Sciences Price Quote

$11.67
-0.01 (0.95%)
(Updated: September 2, 2023 at 6:20 AM ET)

Roivant Sciences Key Stats

Sell
28
Roivant Sciences (ROIV) is a Sell

Day range:
$11.46 - $11.94
52-week range:
$2.87 - $12.01
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
108.29
P/B ratio:
9.9%

Volume:
3.7M
Avg. volume:
3.2M
1-year change:
228.09%
Market cap:
$9B
Revenue:
$61.3M
EPS:
$-1.34

How Much Does Roivant Sciences Make?

Is Roivant Sciences Growing As A Company?

  • What Is Roivant Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 4.01%
  • What Is Roivant Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Roivant Sciences Stock Price Performance

  • Did Roivant Sciences Stock Go Up Last Month?
    Roivant Sciences share price went down by -2.1% last month
  • Did ROIV's Share Price Rise Over The Last Year?
    ROIV share price rose by 228.09% over the past 1 year

What Is Roivant Sciences 52-Week High & Low?

Roivant Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roivant Sciences?

  • How Much Debt Does Roivant Sciences Have?
    Total long term debt quarterly is $429.5M
  • How Much Cash Does Roivant Sciences Have?
    Cash and short term investments quarterly total is $1.4B
  • What Is Roivant Sciences’s Book Value Per Share?
    Book value per share is 1.19

Is Roivant Sciences Cash Flow Positive?

  • What Is ROIV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$841.2M
  • What Is Roivant Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $365M
  • What Is Roivant Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.7M

Roivant Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ROIV return on invested capital is -49.7%
  • What Is Roivant Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is -41.97%
  • What Is ROIV Return On Equity?
    ROE is a measure of profitability and is -87.01%

Roivant Sciences Earnings Date & Stock Price

Roivant Sciences Competitors

  • Who Are Roivant Sciences's Competitors?
    Below is a list of companies who compete with Roivant Sciences or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Akari Therapeutics PLC (AKTX)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • NuCana PLC (NCNA)
    • Verona Pharma PLC (VRNA)

Roivant Sciences Dividend Yield

Data Unavailable

Roivant Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.67%
Revenue: 400.67% -11.69%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 15.88
Upside from Last Price: 35.92%

Major Shareholders

  • How many ROIV shares are owned by institutional investors?
    552.2M ROIV shares are owned by institutional investors
  • How many ROIV shares are owned by insiders?
    61.5M ROIV shares are owned by insiders